Noonan syndrome and related disorders: Alterations in growth and puberty

Reviews in Endocrine and Metabolic Disorders

Volumn 7, Issue 4, 2006, Pages 251-255

  Noonan, Jacqueline A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cardio facio cutaneous syndrome; Costello syndrome; Growth hormone; LEOPARD syndrome; Noonan syndrome; Short stature

Indexed keywords

B RAF KINASE; K RAS PROTEIN;

COSTELLO SYNDROME; GENE MUTATION; HUMAN; LEOPARD SYNDROME; NOONAN SYNDROME; PUBERTY; REVIEW;

ABNORMALITIES, MULTIPLE; BODY SIZE; GERM-LINE MUTATION; HUMANS; LEOPARD SYNDROME; NOONAN SYNDROME; PUBERTY;

EID: 33947147117     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-006-9021-1     Document Type: Review

References (33)

1. Noonan JA. Noonan syndrome an update and review for the primary pediatrician. Clin Pediatr 1994;33:548-55.
2. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001;29:465-8.
3. Gorlin RJ, Anderson RC, Blaw M. Multiple lentigines syndrome. Am J Dis Child 1969;17:652-62.
4. Reynolds JF, Neri G, Hermann JP, Blumberg B, Coldwell JG, Miles PV, et al. New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement - the CFC syndrome. Am J Med Genet 1986;28:413-27.
5. Hennekam RC. Costello syndrome, an overview. Am J Med Genet 2003;117C(1):42-8.
6. Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi G, Tanaka Y, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet 2005;37:1038-40.
7. Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Santa Cruz M, et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Nat Genet 2006;311(5765):1287-90 (online publication).
8. Niihori T, Aoki Y, Narumi Y, Neri G, Cave H, Verloes A, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet 2006;38:294-6.
9. Sharland M, Patton MA, Talbot S, Chitolie A, Bevan DH. Coagulation-factor deficiencies and abnormal bleeding in Noonan syndrome. Lancet 1992;339:19-21.
10. Jamieson CR, van der Burgt I, Brady AF, Van Reen M, Elsawi M, Hol F, et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994;8:357-60.
11. Noordam C, van der Burgt I, Sweep CG, Delemarre-Van de Waal HA, Sengers RC, Otten BJ. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment. Clin Endocrinol (Oxf) 2001;54:53-9.
12. Kirk JM, Betts PR, Donaldson MD, Dunger DB, Johnston DI, Kelnar CJH, et al. Short stature in Noonan syndrome: response to growth hormone therapy. Arch Dis Child 2001;84:440-3.
13. MacFarlane CE, Brown DC, Johnston LB, Patton MA, Dunger DB, Savage MO, et al. Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up. J Clin Endocrinol Metab 2001;86:1953-6.
14. Ahmed MI, Foot AB, Edge JA, Lamkin VA, Savage MO, Dunger DB. Noonan syndrome: abnormalities of the growth hormone/IGF-I axis and the response to treatment with human biosynthetic growth hormone. Acta Paediatr Scand 1991;80:446-50.
15. Romano AA, Blethen SL, Dana K, Noto RA. Growth hormone treatment in Noonan syndrome: the national cooperative growth study experience. J Pediatr 1996;128(Suppl):18-21.
16. Municchi G, Pasquino AM, Pucarelli I, Cianfarani S, Passeri F. Growth hormone treatment in Noonan syndrome: report of four cases who reached final height. Horm Res 1995;44:164-7.
17. Noonan JA, Raaijmakens R, Hall B. Adult height in Noonan syndrome. Am J Med Genet 2003;123A:68-71.
18. Ranke MB, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR. Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr 1988;148:220-7.
19. Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S. Noonan syndrome: relationships between genotype, growth and growth factors. J Clin Endocrinol Metab 2006;91(1):300-6. (Abstract)
20. Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W. Genotype-phenotype correlations in Noonan syndrome. J Pediatr 2004;144:368-74.
21. Ferreira LV, Souza SA, Arnhold IJ, Mendonca BB, Jorge AA. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome. J Clin Endocrinol Metab 2005;90(9):5156-60. (Abstract)
22. Binder G, Neuer K, Ranke MB, Wittekindt NE. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome. J Clin Endocrinol Metab 2005;90(9):5377-81. (Abstract)
23. Cotterill AM, McKeena WJ, Brady AF, Shardland M, Elsawi M, Yamada M, et al. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan syndrome. J Clin Endocrinol Metab 1996;81:2291-7.
24. Sarkozy A, Conti E, Deripa D, Digilio MC, Grifone M, Tandoi C, et al. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndrome. J Med Genet 2003;40:704-8.
25. Sarkozy A, Conti E, Digilio MC, Marino B, Morini E, Pacileo G, et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet 2004;41:e68.
26. Borradori L, Blanchet-Bardon C. Skin manifestations of the cardio-facio-cutaneous syndrome. J Am Acad Dermatol 1993;28:815-9.
27. Kavamura MI, Pomponi MG, Zollino M, Lecce R, Murdolo M, Brunoni D, et al. PTPN11 mutations are not responsible for the cardiofaciocutaneous syndrome. Eur J Hum Genet 2003;11:64-8.
28. Johnson JB, Golabi M, Norton ME, Rosenblatt RM, Feldman GM, Yang SP, et al. Costello syndrome: phenotype, natural history, differential diagnosis and possible cause. J Pediatr 1998;133:441-8.
29. Lin AE, Grossfeld PD, Hamilton RM, Smoot L, Gripp KW, Proud V, et al. Further delineation of cardiac abnormalities in Costello syndrome. Am J Med Genet 2002;111:115-29.
30. Siwik E, Zahka K, Wiesner G. Cardiac disease in Costello syndrome. Pediatrics 1998;101:706-9.
31. Gripp KW, Lin AE, Stabley DL, Nicholson L, Scott CI, Doyle D, et al. HRAS mutation analysis in Costello syndrome. Am J Med Genet A 2006;140:1-7.
32. Kerr B, Einaudi MA, Clayton P, Gladman G, Eden T, Saunier P, et al. Is growth hormone treatment beneficial or harmful in Costello syndrome. J Med Genet 2003;40:e74.
33. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, et al. Diversity and functional consequences of germline and somatic PTPN mutations in human disease. Am J Hum Genet 2006;78:279-89.